Structure CEO warns compounded weight-loss drugs could threaten new obesity treatments as the company prepares to bring its ...
Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback